Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SynAct Pharma AB
AB
Active
Org 5590584826
Scheelevägen 2, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 10 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SynAct Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
10M
8M
5M
3M
0M
2M
2021
5M
+150%
2022
8M
+60%
2023
7M
-12%
2024
7M
0%
2025
EBITDA
SEK millions
0M
-7M
-14M
-22M
-29M
-11M
2021
-21M
-91%
2022
-23M
-10%
2023
-22M
+4%
2024
-13M
+41%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 637
5 144
8 262
6 969
6 839
Staff expenses
—
—
—
—
—
EBITDA
−10 962
−20 671
−23 018
−22 359
−13 115
Depreciation & amort.
−0
—
—
—
—
EBIT
−10 962
−20 671
−23 018
−22 359
−13 115
Net financials
−50 010
−111 420
−126 510
−70 310
−85 030
Profit before tax
−60 966
−130 970
−149 529
−90 623
−98 144
Tax
−0
−0
−0
−0
−0
Net profit
−60 966
−130 970
−149 529
−90 623
−98 144
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
45 334
119 225
230 768
257 757
230 217
Equity
40 404
111 127
214 072
241 360
216 293
Long-term debt
0
0
8 821
8 304
10 606
Short-term debt
4 930
8 098
7 876
8 093
3 318
Total debt
4 930
8 098
16 697
16 397
13 924
Financial ratios
5-year trend
EBITDA margin
-191.8%
This company
15.8%
Market median
1314% below market
2021
2025
Equity ratio
94.0%
This company
38.2%
Market median
146% above market
2021
2025
Return on equity
-45.4%
This company
18.4%
Market median
347% below market
2021
2025
Net profit margin
-1435.1%
This company
8.1%
Market median
17817% below market
2021
2025
Asset turnover
0.03×
This company
1.12×
Market median
97% below market
2021
2025
Debt / equity
0.06×
This company
0.62×
Market median
90% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on SynAct Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
